Morbidity and Mortality Weekly Report: Recommendations and Reports, July 29, 2016 / Vol. 65 / No. RR-4

Details

• Alternative Title:
  U.S. Selected Practice Recommendations for Contraceptive Use, 2016
• Journal Article:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports
• Personal Author:
  Curtis, Kathryn M. ; Jatlaoui, Tara C. ; Tepper, Naomi K. ; Zapata, Lauren B. ; Horton, Leah G. ; Jamieson, Denise J. ; Whiteman, Maura K.
• Corporate Authors:
  Centers for Disease Control and Prevention (U.S.) ; National Center for Chronic Disease Prevention and Health Promotion (U.S.), Division of Reproductive Health
• Description:
  The 2016 U.S. Selected Practice Recommendations for Contraceptive Use (U.S. SPR) addresses a select group of common, yet sometimes controversial or complex, issues regarding initiation and use of specific contraceptive methods. These recommendations for health care providers were updated by CDC after review of the scientific evidence and consultation with national experts who met in Atlanta, Georgia, during August 26–28, 2015. The information in this report updates the 2013 U.S. SPR (CDC. U.S. selected practice recommendations for contraceptive use, 2013. MMWR 2013;62[No. RR-5]). Major updates include 1) revised recommendations for starting regular contraception after the use of emergency contraceptive pills and 2) new recommendations for the use of medications to ease insertion of intrauterine devices. The recommendations in this report are intended to serve as a source of clinical guidance for health care providers and provide evidence-based guidance to reduce medical barriers to contraception access and use. Health care providers should always consider the individual clinical circumstances of each person seeking family planning services. This report is not intended to be a substitute for professional medical advice for individual patients. Persons should seek advice from their health care providers when considering family planning options.
  
  These recommendations supersede the CDC U.S. Medical Eligibility Criteria for Contraceptive Use, 2016.
  
  
• Subjects:
  Contraception / Contraindications Contraception / Methods Contraceptive Agents Contraceptive Behavior Eligibility Determination / Standards Family Planning Services Health Services Accessibility Reproductive Health
• Source:
  Morbidity and Mortality Weekly Report (MMWR): Recommendations and Reports, 2016; v. 65, no. 4
• Series:
  Recommendations and Reports: Morbidity and Mortality Weekly Report (MMWR)
• DOI:
  http://dx.doi.org/10.15585/mmwr.rr6504a1
• ISSN:
  1057-5987 (print) ; 1545-8601 (digital)
• Pubmed ID:
  27467319
• Document Type:
  Journal Issue
• Genre:
  Guideline
• Place as Subject:
  United States
• CIO:
  National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP)
• Division:
  Division of Reproductive Health (DRH)
• Location:
  North America
• Pages in Document:
  72 pdf pages
• Volume:
  65
• Issue:
  4
• Citation:
  Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. Selected Practice Recommendations for Contraceptive Use, 2016. MMWR Recomm Rep 2016;65(No. RR-4):1–66. DOI: http://dx.doi.org/10.15585/mmwr.rr6504a1
• Collection(s):
  Guidelines and Recommendations Morbidity and Mortality Weekly Report (MMWR)
• Main Document Checksum:
  urn:sha-512:598c2065a3f651f92645603219138f72a297a62560e244b9b60fe46d55fb7f7d3ca716b2ad5ccfc43503c58cf2052fb5b8ae4986b731c3e83e29dafc98a2ae97
• Download URL:
  https://stacks.cdc.gov/view/cdc/40515/cdc_40515_DS1.pdf
• File Type:
  [PDF - 879.66 KB ]